MARKETS
Earnings

Nanoviricides Q4 EPS $(0.10), Inline

Sep 28, 2026 · 05:47 PM ET· updated 35m ago

Nanoviricides (AMEX:NNVC) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate. This is a 23.08 percent increase over losses of $(0.13) per share from the same period last year.

Share
Why It Matters

Nanoviricides lost money this quarter, but lost less than last year. When a losing company loses smaller amounts over time, that shows progress toward profitability.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.